Tva Group Inc (PK) (TVAGF) News

DBSCAM’em Linda and Reggie’s little perpetual bank account.

Shareholders funding their lifestyle for a very long time

How about dat Ai ?

Poo, how are those .0006 and .0005 doing ?


DBSCAM’em

BRETT to .22, EAI an AI token to .156. I had taken a small starter a couple of weeks ago at .10

Game on to back under 2.00 if there is no substantial news. The whole sector is goosed by the chatter between governments. No substantial news will mean red once that dies down.

lol. That was funny. Thanks for sharing 😄

That is how the author intended it to be read. If a CEO can't cheer for his own company then nobody can right?
It would be more helpful if we knew exactly when the purchases were made in relation to the breakout of WDLF
that only lasted a number of days in early Feb, 21. I feel that i

Great two weeks has propelled the price to $1.28. Volume was incredible and with meaningful News next week could be the catalyst to move us to over $2/share. If the partnerships are disclosed, and one of them involves Tesla, $2/share will be in the rear view mirror. GLTA

They gave Gelsinger a mission impossible and watched him fail just to give power to some obscure beans counters. It is a deja vu in an industry in which it takes decades to build an awesome enterprise, and a very short time to destroy it. We are light years away from the 'only the paranoid survive

Lmao, the guy that dumped 25% of the year’s volume in one trade knows not only how these scams work, he doesn’t want to get left holding the bag like the CONdog96 🤡Clown has.

Zero chance of me settling for mediocre gains here. I see this one as an opportunity of a lifetime. If it somehow doesn't work out the way I envisage so be it but I'm not going to be missing out on huge gains here when it really heats up. That feeling is not a nice one.

Any suggestion at the point, such as a utility model, is intended to drag on the conservatorship. Time has proved no need of any new models, such as a utility model, etc.

~ $ILLR Triller Group's transformation has begun with ambitious plans set by Bob diamond. Triller + AGBA Forging A New Path Ahead.
https://youtube.com/watch?v=eFKXZzRWDLY

[yt]eFKXZzRWDLY[/yt]

I think they can do 8 million in revenue for the year if everything goes perfectly with the new small detox they bought. However I think the operating costs and payment on defaulted loans will be atleast 9 or 10 million. Revenue isn’t profit so I’m not sure why you focus on revenue and not profit.

Exactly, it is not even sneaky anymore as it is obvious. Simp...wus, and smells like fishy at 60....It is hilarious, I hope this one will chase hardcore as his games are apparent, soft BASHER ‼️🙌💯

BEST SELLERS RANK (BSR) IS 218 62 Estimated Sold on Amazon Since OCT 1 - 4TH Quarter 2024
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Dec

TransCode Therapeutics has received written approval from the Dana Farber Cancer Institute Institutional Review Board (IRB) to proceed with its first-in-human (FIH) Phase 0 clinical trial of TTX-MC138 for the treatment of patients with advanced solid tumours.
Designed to inhibit the pro-metas

NEOM: An Update on the World's Most Ridiculous City (It's Still Ridiculous...)
https://youtu.be/e40Ju-zNyXk?si=ehN2sKx9qYP8t7GM

$ILLR With over 430M+ consumer accounts and a reach of 100M+ social media users, Triller Group is redefining how content is created and shared. Our platform integrates AI and machine learning to deliver unparalleled experiences. #TrillerGroup #DigitalTransformation

https://x.com/trill

See post on Xabout SDRC's $212 Billion Inferred Value with data and due diligence provided.

Agreed

The new setup with mikah is less risky. We are lucky the ceo had deep pockets. And does not take credit card loans to invest in elite. lol

Are you talking about ??

Dr. Tom Fitzgerald joined Steve Darling from Proactive to announce a major milestone: the dosing of the first two patients in the company’s Phase 1 clinical trial for its lead candidate, TTX-MC138. This clinical trial is a multicenter, open-label, dose-escalation, and dose-expansion study designed t